INS and Hyperglycemia: Overall, our findings suggest that pulmonary viral infection in mice featuring types 1 and 2 diabetes-induced hyperglycaemia leads to a marked impairment of lung antiviral adaptive immunity, potentially driving delayed viral clearance and elevated mortality, which is reversible following insulin-mediated glucose lowering.